Prof. Vlad Ratziu discusses the updated subclassification and nomenclature for steatotic liver disease, the therapeutic advance of resmetirom, and the future for MASLD and MASH.
Episode 13: Advances in MASLD and MASH | Medicine Matters: The Springer Medicine Podcast - Listen or read transcript on Metacast
